Overview

Detailed Summary

Kimia Bio-sciences Limited, formerly known as Laurel Organics Limited, focuses on manufacturing bulk drugs and APIs at its plant in Gurgaon, Haryana.
The company faced financial difficulties and was declared a sick unit during 1998-99, but later recovered and moved out of the BIFR purview by 2005.
In 2018, Kimia Biosciences Limited underwent a reverse merger with its holding company, which was holding a majority equity stake.
Kimia has maintained its strategic focus on pharmaceuticals, particularly in manufacturing and supplying APIs, strengthening its market position.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 142 Cr
Volatility: Moderate Risk
P/E Ratio: 15.7
Industry P/E: 32.6
PEG Ratio: 0.1
P/B Ratio: 12.3
52W High: 86.85
52W Low: 26.09

Sales CAGR

1Y: 13.39%
3Y: -1.62%
5Y: 2.27%
10Y: 104.26%

Profit CAGR

1Y: 280.98%
3Y: —
5Y: 47.41%
10Y: —

ROE

TTM: 70.62%
3Y: -32.03%
5Y: -7.43%
10Y: -2.77%

ROCE

TTM: 33.57%
3Y: 7.55%
5Y: 7.42%
10Y: 7.05%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
NATCAPSUQ	148.00	154 Cr	-7.84	0.68	0.00	-4.87	-1.11	-4.56
PARNAXLAB	124.10	144 Cr	11.36	1.60	0.00	12.26	12.71	6.01
KIMIABL	30.04	142 Cr	15.73	12.25	0.00	70.62	33.57	8.92
PANCHSHEEL	100.50	133 Cr	10.76	0.96	0.79	8.89	11.28	7.21
SMRUTHIORG	117.00	132 Cr	29.18	1.86	1.30	6.60	10.56	4.61
ALPA	62.37	131 Cr	11.16	0.72	0.00	10.18	12.57	4.91
Median: 6 Co.	108.75	138 Cr	11.26	1.28	0.00	9.53	11.92	5.46

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	24	26	30	22	28	30	38	24	34	30
Expenses	26	27	26	19	25	25	30	21	31	24
Operating Profit	-1.96	-1.05	4.16	3.71	3.37	5.00	8.18	2.53	2.52	6.55
OPM %	-8.10	-4.02	13.73	16.56	11.96	16.61	21.39	10.73	7.41	21.76
Other Income	0.64	0.58	0.30	0.08	0.37	0.42	0.44	0.85	-0.33	0.10
Interest	1.12	1.31	1.34	1.11	1.04	1.01	1.40	1.75	0.27	0.75
Depreciation	0.82	0.82	0.82	0.90	0.79	0.82	0.88	0.94	0.97	0.85
Profit Before Tax	-3.27	-2.60	2.31	1.78	1.91	3.60	6.34	0.69	0.95	5.05
Tax %	25.08	25.00	22.08	19.66	15.71	-26.94	68.61	13.04	-7.37	-7.72
Net Profit	-2.44	-1.95	1.80	1.44	1.61	4.57	1.99	0.60	1.02	5.44
EPS in Rs	-0.52	-0.41	0.38	0.30	0.34	0.97	0.42	0.13	0.21	1.15

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	1.46	76	94	106	133	125	129	105	119	120
Expenses	2.44	74	88	102	124	124	133	105	99	101
Operating Profit	-0.98	2.47	5.57	4.45	8.38	0.63	-4.98	-0.48	20	19
OPM %	-67.18	3.23	5.93	4.19	6.31	0.51	-3.87	-0.46	17.03	15.89
Other Income	0.59	0.86	1.33	0.96	2.46	0.93	0.17	1.64	1.32	2.08
Interest	0.27	0.58	2.00	2.53	3.39	3.64	4.25	5.05	4.56	5.20
Depreciation	0.35	1.14	1.10	1.66	1.91	2.94	3.33	3.29	3.38	3.43
Profit Before Tax	-1.01	1.60	3.81	1.23	5.53	-5.02	-12	-7.18	14	13
Tax %	7.57	-3.82	-1.30	-12.65	7.77	26.21	24.51	26.10	29.50	30.06
Net Profit	-0.93	1.67	3.86	1.38	5.10	-3.70	-9.35	-5.31	9.61	8.77
EPS in Rs	-0.20	0.09	0.58	0.44	1.08	-0.78	-1.98	-1.12	2.03	1.91
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	7.39	7.39	1.46	1.46	4.64	4.73	4.73	4.73	4.73	4.73
Reserves	-11	-12	0.18	4.00	8.64	14	10	0.73	-4.40	5.23
Borrowings	6.75	8.83	30	30	31	45	41	53	44	33
Other Liabilities	1.24	7.53	27	30	42	43	54	63	56	68
Total Liabilities	4.11	12	58	65	86	107	109	121	100	111
Fixed Assets	3.20	6.66	13	16	18	28	35	34	32	33
CWIP	0.00	3.07	2.48	1.53	5.74	5.77	0.00	0.61	0.58	0.00
Investments	0.00	0.00	0.00	0.01	0.42	0.06	0.06	0.06	0.00	0.00
Other Assets	0.90	2.02	43	48	62	72	74	87	68	78
Total Assets	4.11	12	58	65	86	107	109	121	100	111

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-5.99	-0.74	-7.09	-2.65	0.31	5.97	8.00	-6.77	15	21
Cash from Investing Activity	-0.10	-6.23	-2.36	-2.22	-8.63	-14	-0.71	-2.80	-1.49	-4.70
Cash from Financing Activity	6.09	7.01	9.91	4.42	8.46	7.99	-7.67	9.54	-13	-17
Net Cash Flow	0.01	0.04	0.46	-0.46	0.14	0.35	-0.38	-0.03	-0.03	0.06

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	74.94%	74.94%	74.94%	74.94%	74.94%	74.94%	74.94%	74.94%	74.94%	74.94%	74.94%	74.94%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.38%	0.38%	0.38%	0.38%	0.38%	0.38%	0.38%	0.38%	0.38%	0.38%	0.38%	0.38%
Public	24.68%	24.68%	24.68%	24.68%	24.68%	24.68%	24.68%	24.68%	24.68%	24.68%	24.68%	24.68%
Total Shareholders	12,201	12,147	12,118	12,063	12,110	12,023	12,179	12,231	12,278	12,200	12,616	12,751

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Upgrade

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.